Percentage of bloodstream infection due to Escherichia coli resistant in Indonesia

Indonesia: Percentage of bloodstream infection due to Escherichia coli resistant was 69.7% in 2022. ▬ Flat

Latest (2022)
69.7%
Change on year
down 1.9%
World rank
8th
of 50 countries
All-time high
75.6%
in 2020
All-time low
69.7%
in 2022
Years of data
5
2018–2022

Percentage of bloodstream infection due to Escherichia coli resistant in Indonesia, 2018–2022

0204060802018202020222018: 71.9 %2019: 70.1 %2020: 75.6 %2021: 71.1 %2022: 69.7 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

Indonesia recorded 69.7% for percentage of bloodstream infection due to escherichia coli resistant in 2022. That is the lowest value across all 5 years on record.

Compared with earlier readings it is down 1.9% on the previous year and down 3.0% over five years.

That places Indonesia 8th out of 50 countries with data for 2022, putting it in the top quarter.

Percentage of bloodstream infection due to Escherichia coli resistant in Indonesia, year by year

Annual values for Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) in Indonesia, 2018 to 2022.
Year % Change
2018 71.9%
2019 70.1% -2.4%
2020 75.6% +7.8%
2021 71.1% -6.0%
2022 69.7% -1.9%

Averages by decade

DecadeAverage LowestHighest Years
2010s 71.0% 70.1% 71.9% 2
2020s 72.2% 69.7% 75.6% 3

Countries ranked near Indonesia

  1. 5 Nepal 77.1% compare
  2. 6 Zambia 76.5% compare
  3. 7 Iran (Islamic Republic of) 70.6% compare
  4. 9 Bahrain 63.0% compare
  5. 10 Mali 60.9% compare
  6. 11 North Macedonia 60.0% compare

See the full ranking of 66 places →

More development goals data for Indonesia

All data for Indonesia →

Frequently asked questions

What is percentage of bloodstream infection due to escherichia coli resistant in Indonesia?
Percentage of bloodstream infection due to escherichia coli resistant in Indonesia was 69.7% in 2022, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to escherichia coli resistant recorded in Indonesia?
The highest recorded value was 75.6% in 2020.
What is the lowest percentage of bloodstream infection due to escherichia coli resistant recorded in Indonesia?
The lowest recorded value was 69.7% in 2022.
How does Indonesia rank for percentage of bloodstream infection due to escherichia coli resistant?
Indonesia ranks 8th out of 50 countries with data for 2022.
Where does this Indonesia data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to Escherichia coli resistant in Indonesia. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 10 September 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/indonesia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/indonesia/">Percentage of bloodstream infection due to Escherichia coli resistant in Indonesia</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
66 places, 407 data points, 2016–2022
Last refreshed